VAPRED Study

D-Dimer Microchapters
Home
Patient information
Overview
Historical Perspective
Physiology
Clinical Correlation
Causes of High D-dimer
Diagnostic Role in Thromboembolism
Prognostic Role in Mortality
Prognostic Role in Thromboembolism Occurence
Prognostic Role in Thromboembolism Recurrence
Prognostic Role in Non-Thromboembolism
Clinical Trials
Landmark Trials
Case #1
VAPRED Study On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of VAPRED Study All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on VAPRED Study
CDC on VAPRED Study
VAPRED Study in the news
Blogs on VAPRED Study
Directions to Hospitals Treating D-dimer
Risk calculators and risk factors for VAPRED Study

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Timeline

Timeline
Start Date
Run-In Period
End Date
Status

The previous information was derived from ClinicalTrials.gov on 09/20/2013 using the identification number NCT------.

Study Description

Study Description
Study Type
Study Phase
Study Design
Allocation
Endpoint
Interventional Model
Masking
Study Details
Primary Purpose
Condition
Intervention
Study Arms
Population Size

The previous information was derived from ClinicalTrials.gov on 09/20/2013 using the identification number NCT-----.